The Immunodominant Influenza A Virus M1(58-66) Cytotoxic T Lymphocyte Epitope Exhibits Degenerate Class I Major Histocompatibility Complex Restriction In Humans

Joanna A. L. Choo,Jingxian Liu,Xinyu Toh,Gijsbert M. Grotenbreg,Ee Chee Ren
DOI: https://doi.org/10.1128/JVI.00855-14
IF: 6.549
2014-01-01
Journal of Virology
Abstract:Cytotoxic T lymphocytes recognizing conserved peptide epitopes are crucial for protection against influenza A virus (IAV) infection. The CD8 T cell response against the M1(58-66) (GILGFVFTL) matrix protein epitope is immunodominant when restricted by HLA-A(star)02, a major histocompatibility complex (MHC) molecule expressed by approximately half of the human population. Here we report that the GILGFVFTL peptide is restricted by multiple HLA-C(star)08 alleles as well. We observed that M158-66 was able to elicit cytotoxic T lymphocyte (CTL) responses in both HLA-A(star)02- and HLA-C(star)08-positive individuals and that GILGFVFTL-specific CTLs in individuals expressing both restriction elements were distinct and not cross-reactive. The crystal structure of GILGFVFTL-HLA-C(star)08:01 was solved at 1.84 angstrom, and comparison with the known GILGFVFTL-HLA-A(star)02:01 structure revealed that the antigen bound both complexes in near-identical conformations, accommodated by binding pockets shaped from shared as well as unique residues. This discovery of degenerate peptide presentation by both HLA-A and HLA-C allelic variants eliciting unique CTL responses to IAV infection contributes fundamental knowledge with important implications for vaccine development strategies.IMPORTANCE The presentation of influenza A virus peptides to elicit immunity is thought to be narrowly restricted, with a single peptide presented by a specific HLA molecule. In this study, we show that the same influenza A virus peptide can be more broadly presented by both HLA-A and HLA-C molecules. This discovery may help to explain the differences in immunity to influenza A virus between individuals and populations and may also aid in the design of vaccines.
What problem does this paper attempt to address?